Is MET stock a Buy, Sell, or Hold?

Based on our analysis, MET is currently a WAIT with low confidence. 📊 MIXED SIGNALS: MET shows conflicting indicators. Wait for confirmation before entering.

What is the fair value of MET stock?

Our analysis estimates the fair value range for MET to be between $95.30 and $97.64. The current price is $94.35.

What is the analyst price target for MET?

The average Wall Street analyst price target for MET is $105.75. This implies a potential upside of 12.1% from current levels.

MetLife (MET) Stock: Buy, Sell, or Hold?

MET - MetLife, Inc.

LIFE INSURANCE

$94.35

0.19 (0.20%) ▲

5d: -2.98%

30d: -0.07%

90d: +4.76%

WAIT

LOW Confidence

Protect Your MET Gains

Analysis Updated: Oct 1, 2026 12:00 AM ET

Earnings: Nov 04, 2026

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Sep 29, 2026 at $95.20 · last confirmed Sep 29, 2026

Strength: 6.0/10

Get Alerted When MET Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 MIXED SIGNALS: MET shows conflicting indicators. Wait for confirmation before entering.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 12.2%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$126.19

Based on 8.1% avg growth

INTRINSIC VALUE TODAY

$78.36

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.7x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: MET is currently trading at $94.35, which is considered oversold relative to its 30-day fair value range of $95.30 to $97.64. From a valuation perspective, the stock is trading at a premium (Forward PE: 8.5) compared to its historical average (7.7). At these levels, the market is pricing in 3.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, MET is in a strong uptrend. The price is currently testing key support at $92.21. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $105.75 (+12.1%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD

Historical Trading Range $95.30 - $97.64

Company Quality Score 52/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 78.1%

Protect Your Profits

Holding MET? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
NEUTRAL: Mixed technical signals (44/100)
BULLISH: High volume confirmation
BULLISH: Trading below Wall St target ($105.75)
NEUTRAL: Market pricing in 3.2% annual earnings growth - fairly valued
WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $95.30 - $97.64

Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $92.21

Resistance Level $98.45

Current Trend Strong Uptrend

Technical data as of Oct 1, 2026

Fundamental Context

Forward P/E (Next Year Est.) 8.48

Wall Street Target $105.75 (+12.1%)

Revenue Growth (YoY) 10.5%

Earnings Growth (YoY) 5.8%

Profit Margin 4.6%

Valuation Premium vs History +3.2% premium

PE vs Historical 8.5 vs 7.7 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): +3.2% (market-implied from PE analysis)

1-Year Target $97.37 (+3%)

2-Year Target $100.49 (+7%)

3-Year Target $103.70 (+10%)

3-Yr Target (if PE normalizes) (PE: 8→8) PE COMPRESSION $94.13 (0%)

Earnings growth offset by PE compression

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.4, Growth: 12.2%) $320.62 (+240%)

Base: (SPY PE: 8.5, Growth: 12.2%) $133.32 (+41%)

Bear: (PE: 7.2, Growth: 12.2%) $113.32 (+20%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (8x PE) as earnings recover.

Trailing PE: 18.25 | Current EPS (TTM): $5.16

Bull Case $207.15 (+120%)

Analyst growth 100.0%, PE expands to 20.1

Base Case $188.32 (+100%)

Market implied 100.0%, PE stable at 18.3

Bear Case $64.03 (-32%)

Severe decline -20.0%, PE contracts to 15.5

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: October 02, 2026 5:33 AM ET
Data refreshes hourly during market hours. Next update: 6:33 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is MET showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for MET.

Create Free Account

Already have an account? Log In

Top Rated Insurance - Life Stocks

Top-rated stocks in Insurance - Life by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
UNM Unum Group	BUY 13 analysts	$102	47 HOLD
GL Globe Life Inc	BUY 10 analysts	$194	59 HOLD
ABL Abacus Life Inc.	STRONG BUY 5 analysts	$14	42 HOLD
MFC Manulife Financial Corp	BUY 13 analysts	$34	39 SELL
LNC Lincoln National Corpora…	HOLD 13 analysts	$48	50 HOLD

MFC Manulife Financia…

39 SELL

LNC Lincoln National …

50 HOLD

Advanced MET Option Strategies

Professional options setups generated by AI based on today's MET price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for MET

MET Technical Chart MET Price Prediction MET Earnings Date MET Investment Advisor MET Fair Price Analyzer MET Options Advisor MET Options Chain MET Options Analysis MET Competitors

Compare MET with Peers

MET vs PRU
Which one to buy?

MET vs HIG
Which one to buy?

MET vs ALL
Which one to buy?

MET vs LNC
Which one to buy?

MET vs AFL
Which one to buy?

RGA vs MET

PFH vs MET

AFL vs MET
Winner: MET

Create New Comparison View All Competitors

Tradestie